Outcomes of radiofrequency ablation for hepatocellular carcinoma with concurrent steatotic liver disease
The present research demonstrated that patients with both liver cancer and steatotic liver disease who received curative radiofrequency ablation for liver cancer survived longer compared to those without steatotic liver disease. Maintaining good liver function is an important prognostic factor for survival.
Authors
- Hung‐Chih Yang (ORCID: https://orcid.org/0000-0003-3864-9895)
- Tung‐Hung Su (ORCID: https://orcid.org/0000-0002-6747-7941)
- Chen‐Hua Liu (ORCID: https://orcid.org/0000-0003-3622-9707)
- Pei‐Jer Chen (ORCID: https://orcid.org/0000-0001-8316-3785)
- Jia‐Horng Kao (ORCID: https://orcid.org/0000-0002-2442-7952)
- Chun‐Jen Liu (ORCID: https://orcid.org/0000-0002-6202-0993)
- Chun‐Ming Hong
- Shang‐Chin Huang (ORCID: https://orcid.org/0000-0003-2507-9627)
- Tai‐Chung Tseng (ORCID: https://orcid.org/0000-0003-0420-8311)
- Sih‐Han Liao (ORCID: https://orcid.org/0000-0002-7339-2768)
- Feng‐Pai Tsai
- Shih‐Jer Hsu
Institutions
- National Taiwan University (TW)
- National Taiwan University Hospital (TW)
Publication Details
- Journal
- Cancer
- Published
- 2024-09-06
- DOI
- https://doi.org/10.1002/cncr.35541
- Citations
- 2
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.77
Funders
- Ministry of Health and Welfare
- National Taiwan University Hospital